Additional Hyperbaric Oxygen After Lower Extremity Amputation

Launched by OSLO UNIVERSITY HOSPITAL · Jul 19, 2018

Keywords

ClinConnect Summary

This clinical trial is studying the effects of hyperbaric oxygen therapy on patients who have had a lower limb amputation due to complications related to diabetes, such as chronic wounds or infections. After their surgery, participants will be randomly assigned to either a group that receives this special oxygen treatment or a group that does not. The aim is to see if the therapy can help improve healing and recovery after amputation.

To be eligible for this study, participants should be between the ages of 65 and 87 and must have had an amputation due to serious health issues like infections or poor blood flow. They also need to be cleared for hyperbaric oxygen therapy by a qualified doctor and be able to attend follow-up appointments. It's important to note that those who are pregnant or have dementia will not be able to participate. If you or a loved one qualify and decide to join, you can expect regular check-ins as part of the study to monitor progress and overall health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis.
• • Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician.
• • Able to cooperate and follow up appointments
• • Included within 7 days after final surgery
• Exclusion Criteria:
• • Not fulfilling inclusion criteria
• • Pregnancy
• • Dementia